• About Lareb
    About Lareb
  • Search information about ADRs
    Search information about ADRs
  • Subscribe to newsletter
    Subscribe to newsletter

Updates RSS icon

  • Overview of reports after monkeypox vaccination
    Untill September 2022 The Netherlands Pharmacovigilance Centre Lareb received 118 reports of adverse events after the monkeypox vaccination (Imvanex). The most reported reactions w ...
    Read more
    16 NOV
  • Heavy menstrual bleeding in product information Pfizer and Moderna vaccines
    The EMA recommended to add heavy menstrual bleeding to the product information of the COVID-19 vaccines of Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax). The Netherlands Pharm ...
    Read more
    28 OCT
  • Allergic reactions after COVID-19 vaccination
    Until June 2022 The Netherlands Pharmacovigilance Centre Lareb received almost 4000 reports of symptoms possibly related to acute allergic reactions based on estimated 36 million g ...
    Read more
    14 OCT
  • Dimethyl fumarate and alopecia
    The Netherlands Pharmacovigilance Centre Lareb has received 92 cases about alopecia associated with the use of dimethyl fumarate. Alopecia is not described in the Dutch Summary of ...
    Read more
    09 OCT
  • Anastrozole and depressed mood
    The Netherlands Pharmacovigilance Centre Lareb received 14 reports of depressed mood associated with the use of anastrozole (Arimedex®). In the Summary of Product Characteristics o ...
    Read more
    18 SEP
  • Patient organizations can help enable effective communication of adverse drug reactions
    To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. One possible avenue is to collaborate with patient organiz ...
    Read more
    28 JUL

Home